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The major cause of blindness in the world is cataract. 
WHO estimates 47.8% of global blindness is due to 
cataract. More than 50% of blindness is due to cataract in 
Southeast Asia. Incidence of cataract increases with 
age.
1,2
 Etiology of cataract formation includes age, 
nutritional deficiencies, environmental changes, 
radiation, metabolic diseases like diabetes and oxidative 
stress.2 Ageing is a physiological process that leads to 
gradual decline in antioxidant enzymes. Tissue defense 
system is modulated by endogenous anti-oxidative 
enzymes.3 The enzymes like glutathione reductase and 
peroxidase, and super oxide dismutase are necessary for 
removing the free radicals from the organ system 
including the lens also.4 Single drug is not effective for 
arresting cataract. Researches had shown that four group 
of drugs viz. aldose reductase inhibitors, non-steroidal 
anti-inflammatory drugs, vitamins &minerals, and 
antioxidants &drugs acting on glutathione are effective 
in preventing cataract.5,6 These drugs block the metabolic 
pathways of glucose responsible for diabetic vascular 
dysfunctions which may be due to deposition of sorbitol. 
Their role in the prevention of diabetic cataract in 
animals is now well established.  
The indication of NSAIDs as prophylactic anti-cataract 
agent came from studies on aspirin use in patients with 
rheumatoid arthritis and diabetes.7-10 The anti-cataract 
activity is explained by virtue of their effect on different 
biochemical pathways. NSAIDs with diverse chemical 
structures were reported to retard the phenomenon of 
cataract in experimental animals. 11, 12 Test of drugs have 
been conducted by using oral route. Cataract 
development is a gradual process, for which drugs will 
have to be taken for prolong time with unnecessary 
systemic side effects. Therefore, topical application in 
the form of eye drops is being evaluated to test their anti-
cataract activity of these drugs. NSAIDs after topical 
application was found to have significant anti cataract 
activity by delaying both the onset and progression of 
cataract.10,13The mechanism of anti-cataract activity of 
NSAIDs includes acetylation, inhibition of glycosylation 
and carbamylation of lens proteins. 
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ABSTRACT 
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) has conflicting status in cataract formation, previous data has 
indicated a cataract inducting role as well as a potential protective effect of NSAIDs against cataract formation. Anti -cataract 
efficacy of NSAIDs has been studied widely in different experimental settings. In view of this naproxen is used as standard and 
valdecoxib, a COX II (cyclooxygenase II) inhibitor, is used as test drug to evaluate the protective effects on naphthalene 
induced cataract in albino rats. 
Objective: The objective of the present study was to evaluate the protective effects of naproxen and valdecoxib on naphthalene 
induced cataract in albino rats. 
Materials and methods:6 groups were taken, each group consisting 6 rats. Group I (control) received normal saline orally.  
Group II (control) received normal saline eye drops. Group III received naproxen (4mg/kg) orally. Group IV received naproxen 
eye drops (2%). Group V received valdecoxib (3mg/kg) orally. Group VI received valdecoxib eye drops (2%). Oral dose and 
eye drops were given daily for 10 days prior to induction of cataract. Cataract was induced bygiving naphthalene 1gm/kg orally 
to albino rats. Rats were examined for appearance of lenticular capacity by indirect illumination, direct ophthalmoscopy, slit 
lamp examination daily, and observed for period of thirty days for any mortality. 
Conclusion: Valdecoxib, a COX II selective inhibitor, is not more efficacious than naproxen in retarding progress of 
naphthalene induced cataract. 
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Recently NSAIDs have also been reported to possess 
anti-oxidant properties. In previous literature it is shown 
that naproxen is effective both orally and topically in 
preventing cataract, whereas many other non-selective 
cyclooxygenase inhibitors like aspirin, sulindac and 
indomethacin have also being widely studied and shown 
good results.14,15 COX2 inhibitor group of NSAIDs had 
not been well studied for their anti-cataract activity till 
date.16,17 COX inhibitors have minimal gastric side 
effects and is suitable for chronic use for disease like 
rheumatoid arthritis in elderly who are also likely to 
develop cataract. Cataract being common in elderly, it 
will be fruitful if COX inhibitor like valdecoxib retard 
the development of cataract. 
The present study was designed to evaluate the 
protective effects of naproxen and valdecoxib on 
naphthalene induced cataract in albino rats. 
MATERIALS AND METHODS 
Animals: Healthy Wistar albino rats of either sex, 
weighing between 250-300 g were used in the study. 
They were housed in clean metallic cages and were 
maintained on standard laboratory diet and water ad-
libitum. After a five day acclimatization period the rats 
were used for the study. The study was started after 
getting clearance from Institutional Ethics Committee 
and conducted as per CPCSEA guidelines.  
Drugs used for induction of cataract: Naphthalene crystal 
are crushed in mortar using pestle and dissolved in warm 
liquid paraffin to make suspension. Cataract was induced 
by oral administration of naphthalene 1g/kg in albino 
rats.11-13 
Drugs used for study: Naproxen is a white, odourless or 
almost odourless, hygroscopic crystalline powder. It was 
prepared as suspension in gum acacia of 200mg per ml. 
A dose of 4mg/kg/day was administered to the rats. A 
suspension of 2% naproxen powder in normal saline was 
prepared using 1 g of drug in 100 ml of normal saline to 
be used as eye drops. Valdecoxib is a white odourless or 
almost odourless, hygroscopic crystalline powder which 
was prepared as a suspension in gum acacia of 300mg 
per ml. A dose of 3 mg/kg/day was administered to the 
rats. 
Control drugs/vehicle:  A 5% suspension of gum acacia 
was prepared for administration to control rats. 0.9% 
sodium chloride is used as both for eye drops as control. 
Oral administration of drugs: The animals were held 
gently but firmly at the time of feeding. A suitable 
wooden mouth gag was placed between the teeth of the 
rat taking care not to cause any injury to the animal. A 
polythene feeding tube lubricated with liquid paraffin 
was passed through the hole in the mouth gag into the 
stomach of the rat. After ensuring that the tube was in the 
stomach and not in the airway (by looking for air bubbles 
coming out of the tube into a beaker filled with water), 
the required amount of the drug was injected into feeding 
tube using a syringe. About 1 ml of normal saline (dead 
space of the tube) was injected after each drug so that 
any drug remaining in the tube was also delivered into 
the stomach. The tube was gently pulled out after the 
completion of drug administration. 
Administration of eye drops: Rats were restrained 
manually with the help of assistant, two drops were 
instilled on cornea of both eyes, and animal was 
restrained for 10 minutes for drug to have its effect. 
Thirty-six adult albino rats were taken and divided into 
six groups with six animals in each. Group I (control) 
received normal saline orally.  Group II (control) 
received normal saline eye drops. Group III received 
naproxen (4mg/kg) orally. Group IV received naproxen 
eye drops (2%). Group V received valdecoxib (3mg/kg) 
orally. Group VI received valdecoxib eye drops (2%). 
Oral dose and eye drops were given daily for 10 days 
prior to induction of cataract. 
Examination was done daily to check for lenticular 
capacity by indirect illumination, direct ophthalmoscopy, 
slit lamp examination, and observed for any mortality for 
period of thirty days. Initiation and measurement of 
lenticular opacity was graded into four stages.18 
1. First stage was invasion of lens by vacuoles on 
periphery.  
2. Second stage was presence of linear opacities 
cataract.  
3. Third stage was presence of plaques and clouding of 
lens.  
4. Fourth stage was mature cataract. 
Statistical analysis: The data were analyzed by two way 
ANOVA and followed by post hoc Tukey’s test. P<0.05 
was considered to be statistically significant. 
RESULTS 
Naproxen significantly delayed appearance and 
progression of cataract than valdecoxib when given via 
oral route. Whereas, naproxen were just marginally 
effective and valdecoxib was not at all effective in 
preventing cataract when applied topically as eye drops. 
Control 
 All rats from control group subjected to naphthalene 
challenge developed cataract (100%). (Table 1 and 2). 
There was no mortality till end of thirty days of 
observation.
 
Table 1: Effect of oral gum acacia on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 6.1+/-1.4 
II 6 100 9.2+/-1.1 
III 6 100 12.3+/-2.1 
IV 6 100 16.6+/-1.8 
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Table 2: Effect of normal saline eye drops on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 3.8+/-0.5 
II 6 100 7.2+/-1.1 
III 6 100 12.1+/-1.4 
IV 6 100 14.5+/-1.5 
 
Effect of Oral naproxen on naphthalene induced cataract in albino rats: 
Oral naproxen significantly delayed the development of cataract at dose of 4 gm/kg (p<0.001). (Table 3) Mature 
cataract was developed only in two rats at end of 30 days. There was no mortality till end of thirty days of observation. 
Table 3: Effect of oral naproxen on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 18.4+/-2.4 
II 6 100 25.5+/-1.4 
III 5 83.33 35.7+/-1.9 
IV 5 83.33 42+/- 4.8 
 
Effect of naproxen eye drops on naphthalene induced cataract in albino rats: 
Naproxen eye drops (2%) did not have significant effect on development of cataract to various stages (Table 4). Mature 
cataract developed in all rats at end of 30 days. There was no mortality till end of thirty days of observation. 
Table 4: Effect of naproxen eye drops on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 9.1+/-1.7 
II 6 100 14.2+/-2.1 
III 6 100 17.3+/-2.6 
IV 6 100 19.4+/-2.8 
 
Effect of Oral valdecoxib on naphthalene induced cataract in albino rats: 
Oral valdecoxib significantly delayed the development of cataract to various stages with dose of 3gm/kg (p<0.05). 
(Table 5) Mature cataract was developed in all rats at end of 30 days. There was no mortality till end of thirty days of 
observation. 
Table 5: Effect of oral valdecoxib on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 12.1+/-0.7 
II 6 100 17.6+/-1.1 
III 6 100 23.3+/-2.4 
IV 3 50 28.6+/-3.8 
 
Effect of valdecoxib eye drops on naphthalene induced cataract in albino rats: 
Valdecoxib eye drops (2%) showed no significant effect on development of cataract (Table 6). Mature cataract 
developed in all rats at end of 30 days. 
Table 6: Effect of valdecoxib eye drops on naphthalene induced cataract in albino rats 
Stage of cataract Rats no. Developing cataract % Days (M&D) of appearance of cataract 
I 6 100 5.2+/-0.8 
II 6 100 8.3+/-1.6 
III 6 100 14.3+/-1.9 
IV 6 100 16.2+/-1.4 
 
DISCUSSION 
Comparative studies on anti-cataract activity of two 
NSAIDs revealed that, naproxen is better than valdecoxib in 
delaying the development of cataract. It may be due to 
inhibition of lens aldose reductase (AR) by NSAIDs.
19 
The 
mechanism by which naphthalene induced cataract may be 
by its direct toxic effect reducing glutathione levels.
20,21
 In 
this model only oral naproxen could give some protection. 
The probable mechanism producing anti cataract effects by 
naproxen and other NSAIDs can be due to acetylation, 
inhibition of glycosylation and carbamylation of lens 
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proteins, and possibly also due to antioxidant and inhibition 
of aldose reductase.
19,21 
The concentration of glutathione, a 
tripeptide thiol decreases with age in the lens and more 
markedly in cataracts.
22,24 
An approach to glutathione level 
inside the lens by its increased synthesis or decreased 
breakdown was tried by some groups using agents acting 
against glutathione. The potential role of vitamins and anti-
oxidants in preventing various diseases is well 
documented.
4,23,25 
Various substances with diverse chemical 
structures and properties like derivatives of amino acids 
containing germanium compounds, pantethine, glutathione 
isopropyl ester etc. have been reported to have protective 
effect against cataract in different experimental models. 
Further studies focusing on the biochemical pathway is 
needed to reveal the exact mechanism. This study provides 
the lead for clinical study to reveal the possibilities of 
prevention of age related cataract by systemic 
administration as well as topical administration of NSAIDs 
like naproxen and valdecoxib.  
CONCLUSION  
Naproxen, a nonselective COX inhibitor, was more 
effective than valdecoxib, a COX II selective inhibitor, in 
retarding the development of naphthalene induced cataract. 
Oral dosage form was found to be more effective than 
topical form. The results of our previous study on celecoxib 
and naproxen also support the findings of this study.
26 
Despite several known and unknown aspects of the use of 
COX II selective inhibitors in cataract, these drugs have 
potential to be developed as a model drug to delay the 
progression of cataract only after proving its efficacy and 
safety through clinical studies. 
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